Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2678 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

SciClone’s Phase III hepatitis trial fails endpoint

The thymalfasin treatment group did not achieve statistical significance for the primary endpoint of sustained virological response (SVR) as assessed in the primary analysis population, ie, the intent-to-treat

Prolexys raises $20 million in financing

Included among the purchasers of the shares is Peter Friedli, the company’s chairman, individually. The board of directors of the company, including all of the company’s independent directors,

Hospira Q3 net income up

The company has reported net sales of $925.5 million for the third quarter of 2008, an increase of 10.4%, compared to $838 million posted in the third quarter

Health-Robotics forms partnership with AHCSC-Olayan

Arabian Health Care Supply (AHCSC-Olayan) desires to safely, accurately and cost-effectively automate the preparation of life-critical hazardous and non-hazardous IV Admixtures with Health Robotics’s CytoCare and IV Station